Abstract
Enhancers regulate lineage choice and the developmental timing of antigen receptor gene rearrangements. The transcription factor NF-κB has been implicated as a key component of the recombination and transcription activation potential of the immunoglobulin κ chain gene intronic enhancer. Here, I discuss the implications of the new observation that an NF-κB binding site-mutated enhancer in the correct biological context does not appear to affect κ gene expression.
Original language | English (US) |
---|---|
Pages (from-to) | 1099-1102 |
Number of pages | 4 |
Journal | Journal of Experimental Medicine |
Volume | 200 |
Issue number | 9 |
DOIs | |
State | Published - Nov 1 2004 |
Externally published | Yes |
ASJC Scopus subject areas
- Immunology